Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial

Published:2021-09-13 Issue: Volume: Page:1-11
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Bertrand D¹,Stouten V¹,De Cock D¹,Pazmino S¹,Doumen M¹²,de Wergifosse I³,Joly J²,Badot V⁴,Corluy L⁵,Hoffman I⁶,Taelman V⁷,De Knop K⁶,Geens E⁸,Langenaken C³,Lenaerts JL³,Lenaerts J²,Walschot M⁹,Mannaerts J¹,Westhovens R¹²,Verschueren P¹²

Affiliation:

1. Skeletal Biology and Engineering Research Center, KU Leuven Department of Development and Regeneration, Leuven, Belgium

2. Rheumatology, University Hospitals Leuven, Leuven, Belgium

3. Reuma Instituut Hasselt, Hasselt, Belgium

4. Rheumatology, CHU Brugmann, Brussels, Belgium

5. Rheumatology, AZ Herentals, Herentals, Belgium

6. Rheumatology, GZA Sint-Augustinus Antwerpen, Antwerpen, Belgium

7. Rheumatology, Heilig Hart Ziekenhuis Leuven, Leuven, Belgium

8. Rheumatology, ZNA Jan Palfijn Antwerpen, Antwerpen, Belgium

9. Rheumatology, UZA, Antwerpen, Belgium

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2021.1955467

Reference36 articles.

1. Biologicals in rheumatoid arthritis: current and future

2. Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis

3. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

5. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

2. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

3. Response to: comment on “validation and predictive capacity of a dutch version of the FLARE‐RA questionnaire within the context of a TNFi‐tapering trial”;Clinical Rheumatology;2023-09-28

4. Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial;Annals of the Rheumatic Diseases;2023-08-22

5. Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial;Scandinavian Journal of Rheumatology;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3